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Th cells producing IL-17 playa pro-inﬂammatory role at mucosal surfaces. Treg at the same
sites dampen inﬂammation and prevent immunopathology. Th cells producing IL-17 (Th17)
and Treg are thought to be distinct populations deﬁned by expression of the transcription
factors ROR-ct and Foxp3, respectively. Here, we show that mouse CD25
+Foxp3
+ Treg can be
converted into a hybrid T-cell population characterized by the expression of Foxp3 and
ROR-ct and the production of IL-17. Conversion was observed upon coculture with DC
selectively activated via dectin-1, a C-type lectin receptor involved in fungal recognition,
and depended on IL-23 produced by DC. Within the Foxp3
+ population, only Foxp3
+ROR-ct
+
T cells but not Foxp3
+ROR-ct
-–T cells become Foxp3
+IL-17
+ T cells. These results indicate
that some Foxp3
+ T cells can produce IL-17 while retaining Foxp3 expression and suggest
that Treg could play an unexpected pro-inﬂammatory role in some settings.
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Introduction
Our immune system identiﬁes pathogens in part by recognizing
signatures present in microbes, so-called PAMP, via speciﬁc
germline encoded PRR [1]. Recognition of PAMP by PRR leads to
an immediate innate response designed to contain infection and
may also result in the mobilization of adaptive defense mechan-
isms. The translation of PAMP presence into adaptive immunity is
carried out by specialized leukocytes called DC and results in
distinct responses matched to the nature of the offending
microbe. For CD4
+ T cells, infection with intracellular bacteria
tends to induce responses dominated by Th1 cells, whereas
extracellular parasites often promote Th2-biased responses.
Some bacteria and fungi promote a third type of response
deﬁned by the induction of Th cells producing IL-17 (Th17)
[2–4]. Th17 cells are pro-inﬂammatory cells characterized by the
expression of IL-17A, IL-17F, IL-21, IL-22, IL-23R and the
transcription factors ROR-gt and ROR-a [5–7]. They have been
implicated in several models of autoimmunity [8–11] but
under normal conditions may play a role in protection from
infection at mucosal surfaces [2]. IL-6 and TGF-b are key
cytokines required for lineage commitment of murine Th17
[2, 8, 12] whereas IL-23 is a critical factor for sustaining these
cells and is required for the acquisition of their pathogenic
function in vivo [9, 13].
Treg are important regulators of potentially detrimental
responses against normal self-constituents or commensal
microbes and loss of Treg function leads to autoimmune and
inﬂammatory diseases [14, 15]. Treg are characterized by the
expression of CD25 and Foxp3, the latter being a transcription
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efactor required for the maintenance of the Treg lineage
[15, 16]. Like Th1, Th2 and Th17 cells, Foxp3
+ Treg can be
generated in the periphery from newly activated CD4
+ T cells.
The differentiation pathways of such inducible Treg and those of
Th17 cells are closely related as both processes require the
presence of TGF-b [8]. Notably, it has recently been found that
fully differentiated Treg can themselves be converted into Th17
cells in mice [17–19] and humans [20]. This process is accom-
panied by extinction of Foxp3 expression and upregulation of
ROR-gt [18]. Interestingly, some cells in the mouse can coexpress
Foxp3 and ROR-gt [21, 22] and could represent an intermediate
in this process or, alternatively, an intermediate cell in the
differentiation of naı ¨ve T cells into Th17/Treg. Foxp3
+ROR-gt
+
cells behave as bona ﬁde Treg, like their ROR-gt
 counterparts,
and produce IL-10 but not IL-17 [22]. Thus, the available data
suggest that, although Foxp3 and ROR-gt can be coexpressed in
CD4
+ T cells, Foxp3 expression and IL-17 production are
mutually exclusive. This has led to the notion that regulatory and
inﬂammatory T-cell programs are antagonistic [18, 21].
Dectin-1 is a Syk-coupled C-type lectin receptor for b-glucans
involved in the innate recognition of fungi and some bacteria.
Activation of the dectin-1 pathway in DC leads to the generation
of Th17 cells both in vitro and in vivo [4]. Here, we show that
dectin-1-activated DC can directly interact with CD25
+Foxp3
+
Treg and instruct them to become IL-17-producers. Notably, in
contrast to previous studies, we ﬁnd that such Treg do not
extinguish the expression of Foxp3. Instead, they become a
population of Foxp3
+IL-17
+ T cells that deﬁes classiﬁcation
as either Treg or Th17 and could play an important role in
inﬂammation.
Results
CD4
+CD25
+ T cells become IL-17 producers in response
to curdlan-stimulated DC
We have previously reported the induction of Th17 cells in
cocultures of CD4
+ T cells and DC stimulated with the dectin-1
agonist, curdlan [4]. The emergence of a substantial fraction of
IL-17-producing cells required the presence of both CD4
+CD25

and CD4
+CD25
+ cells [4]. To further investigate the role of CD4
+
CD25
+ cells, we puriﬁed naı ¨ve (CD4
+CD25
CD62L
hiCD44
lo)o r
CD4
+CD25
+ T cells from C57BL/6 mice and cultured each
population individually with BM-derived DC (BMDC) plus
a-CD3 mAb in the presence of curdlan or CpG (a TLR9 agonist).
In cultures in which naı ¨ve T cells were the starting population,
inclusion of CpG induced development of T cells that preferen-
tially produced the Th1 cytokine IFN-g rather than IL-17 upon
restimulation (Fig. 1A and B). The inverse was observed in the
presence of curdlan (Fig. 1A and B), as previously reported [4].
Notably, in CD4
+CD25
+ T-cell cultures, neither curdlan nor CpG
led to the development of IFN-g-producing cells but curdlan
promoted the appearance of a large frequency and absolute
number of cells able to produce IL-17 upon restimulation
(Fig. 1A–C). This was accompanied by greater expansion of total
CD4
+CD25
+ T cells in curdlan-containing cultures when
compared with cultures containing CpG or lacking any innate
stimulus (Fig. 1C), suggesting that factors produced by DC in
response to curdlan favor proliferation and/or survival of
CD4
+CD25
+ T cells and induce development of an IL-17-
producing population.
Curdlan-activated DC induce the generation of
Foxp3
+IL-17
+ T cells
CD4
+CD25
+ T cells include activated T cells as well as a large
population of Treg expressing Foxp3 [23]. We therefore set up
cultures with a pure Foxp3
+ T-cell population isolated by cell
sorting from depletion of regulatary T-cell (DEREG) mice (or
from radiation chimeras bearing BM from DEREG mice), which
express GFP fused to the primate diphteria toxin receptor under
the control of foxp3 gene regulatory regions [24]. As for the
total CD4
+CD25
+ T cells used previously, CD25
+GFP
+ DEREG T
cells proliferated more extensively when curdlan was included in
the cultures than when no innate stimulus was present (Fig. 2A).
To account for a possible role of proliferation, we compared
curdlan with IL-2 (Fig. 2A, Treg control), which acts as a Treg
mitogen, and independently analyzed the blast and the resting T-
cell population for expression of Foxp3 and the ability to produce
IL-17 upon restimulation. Blast and non-blast cells were
selected by forward- and side-scatter criteria, whereas
Foxp3 expression was assessed by nuclear staining with a speciﬁc
mAb to directly measure the presence of the protein at the
time of analysis. As expected, we observed Foxp3
+IL-17
 cells in
Treg control cultures and Foxp3
IL-17
+ cells in Th17 control
cultures. However, in curdlan-containing cultures of Foxp3
+
T cells and DC, we observed an accumulation of Foxp3
+IL-17
+
double-positive cells, which were especially noticeable
in the blast fraction (Fig. 2B). T cells producing IL-17 and
coexpressing Foxp3 continued to accumulate over time in
curdlan-containing cultures and represented one-fourth of the
cells by day 7 (Fig. 2C). At both time points, we detected
the presence of transcripts associated with Th17 cell fate
such as ROR-gt, IL23R and, to a lesser extent, IL-17F (Fig. 2D).
Foxp3 transcripts were also found in these cultures, consistent
with the staining data (data not shown). We conclude that, in
response to BMDC stimulated with curdlan, Foxp3
+ cells can give
rise to a T cell capable of coexpressing Foxp3 and IL-17, which
constitutes a distinct phenotype from classical Th17 or Treg.
Foxp3
+ROR-ct
+ but not Foxp3
+ROR-ct
 T cells become
Foxp3
+IL-17
+ T cells
Foxp3
+ Treg are heterogeneous and include a fraction that
coexpresses ROR-gt and produce little or no IL-17 [21, 22]. Given
the importance of ROR-gt in differentiation of conventional
Th17 CD4
+ T cells [5], we wondered whether Foxp3
+ROR-gt
+
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+IL-17
+ double-positive
cells. We therefore compared ROR-gt
+ and ROR-gt
 Treg
isolated from chimeric mice reconstituted with BM from Rorc(gt)-
Gfp
TG mice, in which GFP reports ROR-gt expression [22]. To obtain
Treg from those mice, we sorted cells based on the expression of
CD4, CD25 and folate receptor 4, which closely mirrors Foxp3
expression [25]. We conﬁrmed that the majority of sorted
CD25
+FR4
+ CD4
+ T cells express Foxp3 (Fig. 3A). We then
prepared donor origin CD25
+FR4
+ T cells from Rorc(gt)-Gfp
TG
chimeric mice, which were sub-divided into GFP
+ and
GFP
 fractions and separately cultured with BMDC and a-CD3 in
t h ep r e s e n c eo fc u r d l a n( F i g .3 B ) .N o t a b l y ,o n l yC D 2 5
+FR4
+GFP
+
and not CD25
+FR4
+GFP
 fractions were able to generate
IL-17-producing cells (Fig. 3B). The majority of these cells
coexpressed Foxp3 (Fig. 3B) as observed in experiments with
DEREG T cells (see above). In addition, a proportion of IL-17
+ cells
were negative for Foxp3 (Fig. 3B), probably reﬂecting expansion of
contaminating ROR-gt
+Foxp3
 cells present in the starting popula-
tion, which correspond to Th17 cells (Fig. 3A). We conclude that the
Foxp3
+ROR-gt
+ but not the Foxp3
+ROR-gt
 subset can be induced
to produce IL-17 after culture with DC in the presence of a dectin-1
agonist.
Figure 1. Curdlan-stimulated DC promote IL-17 production by CD4
+CD25
+ T cells. (A) FACS-sorted naı ¨ve T cells or CD4
+CD25
+ T cells from C57BL/6
mice were cocultured for 5 days with BMDC and soluble a-CD3 in medium alone or in the presence of curdlan or CpG. Half of the content of each
well was restimulated on day 5 for 48h with coated a-CD3 and cytokine production was determined by sandwich ELISA. (B) same as part A, but
cells were restimulated on day 5 with PMA, ionomycin and brefeldin A for 4h and the presence of intracellular cytokines was analyzed by ﬂow
cytometry. Data show IFN-g and IL-17 after gating on CD4
+ cells. (C) Total numbers of CD4
+IL-17
+ T cells or CD4
+ T cells obtained on day 5 in
cultures containing CD4
+CD25
+ T cells. Graph shows mean+SEM of three independent experiments. Data are representative of two to six
independent experiments. N.D., not done.
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We have previously shown that curdlan stimulation of DC
leads to production of IL-23 but not IL-12 p70 [4]. To address
the role of IL-23 in the generation of Foxp3
+IL-17
+ T cells,
we cultured IL-23-deﬁcient (p19
/) or wild-type BMDC
with Foxp3
+ T cells from DEREG mice in the presence of
curdlan. Notably, the frequency and number of Foxp3
+IL-17
+
T cells was markedly decreased when p19
/ BMDC were
used as APC (Fig. 4A and B) while CD4
+ T-cell expansion
was unaffected (Fig. 4B). The appearance of ROR-gt and
IL-23R transcripts in curdlan-containing cultures was also
IL-23 dependent (Fig. 4C). When curdlan was replaced with
IL-23, we obtained similar frequencies of Foxp3
+IL-17
+ T cells
(Fig. 4D) but T-cell expansion was reduced, resulting in
lower numbers of Foxp3
+IL-17
+ T cells at the end of the
culture (Fig. 4E). These data suggest that IL-23 is necessary
but not sufﬁcient for maintaining the phenotype and/or survival
of Foxp3
+IL-17
+ T cells.
Discussion
Innate signals play a key role in determining the class of adaptive
immune response against infection. In this study, we have shown
that innate stimulation via the dectin-1 pathway allows DC to
Figure 2. Curdlan-stimulated DC induce the generation of Foxp3
+IL-17
+ T cells. (A) CFSE-labeled CD4
+CD25
+GFP
+ DEREG T cells were cultured for 5
days with wild-type BMDC and soluble a-CD3 in the absence (NT) or presence of curdlan or rhIL-2 (‘‘Treg’’), as indicated. Plots show CFSE proﬁle
after gating on CD4
+ cells. (B) As in (A) but with the addition of a ‘‘Th17’’ control consisting of CD4
+GFP
CD25
 T cells cultured with BMDC, a-CD3
and IL-6+TGF-b in the presence of neutralizing antibodies to IFN-g and IL-4. All cells were restimulated on day 5 with PMA, ionomycin and
brefeldin A for 4h and the expression of Foxp3 and IL-17 was analyzed by gating separately on CD4
+ cell blasts or non-blasts by ﬂow cytometry.
(C) Analysis of parallel cultures from part B on day 7. (D) RT-PCR analysis of transcripts for ROR-gt, IL-17F and IL-23R in the indicated cultures at 5
and 7 days. Data are representative of two to six independent experiments.
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+Foxp3
+ T cells to become Foxp3
+IL-17
+ T cells.
This process is distinct from the differentiation of naı ¨ve T cells in
curdlan-containing cocultures [4], which generates Th17 cells
that do not express Foxp3 (data not shown). Previous
reports have demonstrated that Foxp3
+ T cells can be converted
into Th17 cells in vitro and in vivo under certain conditions
[17–20]. In those studies, Foxp3
+ T cells may pass through a
transient stage characterized by the coexpression of Foxp3 and
IL-17 before downregulating Foxp3. A distinct hallmark
of the cells described in this study is that they maintain or even
increase the expression of Foxp3 while acquiring the ability to
produce IL-17.
Dectin-1 signaling in DC induces the production of several
cytokines, including IL-2, IL-6, IL-10, TNF-a and IL-23 [4].
We have shown that IL-23 is essential to induce but not
sufﬁcient to sustain the generation of Foxp3
+IL-17
+ T cells.
IL-23 might act synergistically with IL-6 and TNF-a, both of which
contribute to the generation of Th17 cells [12]. Dectin-1-acti-
vated DC also produce IL-2, which could contribute to the
generation of Foxp3
+IL-17
+ T cells. Indeed, although IL-2 acts as
an inhibitor of Th17 differentiation from naı ¨ve CD4
+ T cells [26],
it potentiates the expression of Foxp3 in Treg [27]. We propose
that the unique balance of cytokines induced in DC by dectin-1
stimulation may be particularly suited to the generation of
Foxp3
+IL-17
+ T cells, with IL-23, TNF-a and IL-6 favoring IL-17
production and IL-2 sustaining Foxp3 expression. IL-10, which is
also produced at high levels by DC stimulated via the
dectin-1/Syk pathway [4, 28, 29], could potentially help main-
tain Treg markers and/or Treg activity.
Foxp3
+IL-17
+ T cells arise from the Foxp3
+ROR-gt
+ Treg
subset and not the Foxp3
+ROR-gt
 population, indicating that
the Foxp3
+ROR-gt
+ population possesses the ability to produce
IL-17 under certain conditions of innate immune challenge. In
turn, this implies that Foxp3
+ T cells are not being genetically
reprogrammed to become IL-17 producers but that the appro-
priate cytokine milieu can trigger IL-17 production in cells that
already express the genetic machinery required to perform that
function.
The fact that conditions of innate stimulation with fungal
products favor the development of a novel population of
Foxp3
+IL-17
+ cells may have important implications. Fungal
infections have been linked to IL-17 responses [4] and
IL-17-deﬁcient mice are more susceptible to infection with
Candida albicans [30]. In addition, human memory CD4
+ T cells
speciﬁc for C. albicans are skewed toward Th17 [3, 31] and
STAT3-mediated Th17 deﬁciency in humans is associated
with increased susceptibility to C. albicans infection [32].
Whether Foxp3
+IL-17
+ T cells participate in anti-fungal
immunity or whether they retain regulatory activity that could
counteract the detrimental effects of overexuberant Th17
responses [33] remains to be determined. Consistent with the
latter possibility, it has previously been reported that DC acti-
vated by yeast particles induce T cells with regulatory activity
[29]. Notably, small numbers of cells coexpressing Foxp3, ROR-gt
and IL-17 have been previously noticed in mouse gut lamina
propria [21]. By developing techniques for enriching and isolat-
ing Foxp3
+IL-17
+ T cells from animals and patients, we hope that
multiple questions regarding their role can begin to be addressed.
Materials and methods
Mice
C57BL/6 mice were obtained from Charles River. DEREG mice
[24] were bred at Technische Universita ¨tM u ¨nchen or at Cancer
Figure 3. Foxp3
+ROR-gt
+ but not Foxp3
+ROR-gt
- T cells become
Foxp3
+IL-17
+ T cells in response to curdlan-activated BMDC.
(A) FACS-sorted CD4
+CD25
+FR4
+ and CD4
+CD25
-FR4
- T cells from
C57BL/6 mice stained for intracellular Foxp3. (B) FACS-sorted CD4
+
CD25
+FR4
+GFP
+ and CD4
+CD25
+FR4
+GFP
 T cells from Rorc(gt)-Gfp
TG
chimeras were cocultured with wild-type BMDC and soluble a-CD3 in
the presence of curdlan. Cells were restimulated on day 5 with PMA,
ionomycin and brefeldin A for 4h and the expression of Foxp3 and
IL-17 on CD4
+ cell blasts was analyzed by ﬂow cytometry. Data are
representative of two independent experiments.
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deﬁcient mice [34] were provided by A. MacDonald (Edinburgh,
UK) with kind permission from N. Ghilardi, Genentech, and were
bred at Cancer Research UK in speciﬁc pathogen-free conditions.
Rorc(gt)-Gfp
TG mice [22] were bred at Institut Pasteur. Radiation
chimeras using BM from DEREG or Rorc(gt)-Gfp
TG mice were
generated at Cancer Research UK. All animal experiments were
performed in accordance with national and institutional guide-
lines for animal care.
In vitro T-cell assays
CD4
+CD25
CD62L
hiCD44
lo (naı ¨ve) and CD4
+CD25
+ cells from
C57BL/6 mice or CD4
+GFP
+CD25
+ and CD4
+GFP
CD25
 cells
from DEREG mice or DEREG BM chimeras were puriﬁed from
spleen and lymph nodes. CD4
+GFP
+CD25
+FR4
+CD45.1
 and
CD4
+GFP
CD25
+FR4
+ CD45.1
 cells from Rorc(gt)-Gfp
TG BM
chimeras or CD4
+CD25
+FR4
+ and CD4
+CD25
FR4
 cells
from C57BL/6 mice were puriﬁed from mesenteric lymph
node. Cell puriﬁcation was performed by cell sorting using
a MoFlo (Dako Cytomation) or a FACSAria cell sorter (BD
Biosciences); 510
4 sorted T cells were cocultured with 210
4
BMDC generated with GM-CSF as described previously [4]
and 0.2mg/mL of soluble anti-CD3e i nt h ep r e s e n c eo ra b s e n c e
of 50mg/mL curdlan (Wako; suspended in PBS at 10mg/mL),
0.5mg/mL CpG oligonucleotide 1668 (CpG; Sigma) or 10ng/mL
IL-23 (eBiosciences).
Th17 control consisted of CD4
+GFP
CD25
 Tc e l l sf r o m
DEREG mice or DEREG BM chimeras cocultured with BMDC in the
presence of 10ng/mL of TGF-b (Sigma), 20ng/mL of IL-6 (RnD
systems) and neutralizing antibodies against IFN-g (2mg/mL) and
IL-4 (2mg/mL). Treg control consisted of CD4
+GFP
+CD25
+ cells
from DEREG mice or DEREG BM chimeras cocultured with BMDC
in the presence of 100IU/mL of rhIL-2 (RnD systems). In some
experiments, sorted CD4
+GFP
+CD25
+ T cells were labeled with
2mM CFSE for 12min at 371Cb e f o r ec u l t u r e .
Cells from cultures were restimulated on day 5 or 7 for 4h
with phorbol 12-myristate 13-acetate (10ng/mL; Sigma), iono-
mycin (1mg/mL; Calbiochem) and brefeldin A (5mg/mL; Sigma).
Figure 4. IL-23 drives the generation of Foxp3
+IL-17
+ T cells in response to curdlan-activated BMDC. (A) FACS-sorted CD4
+CD25
+GFP
+ DEREG T cells
were cultured with wild-type or p19
/ BMDC plus soluble a-CD3 in the presence of curdlan. Cells were restimulated on days 5 and 7 with PMA,
ionomycin and brefeldin A for 4h and the expression of Foxp3 and IL-17 on CD4
+ cell blasts was analyzed by ﬂow cytometry. (B) Total numbers of
Foxp3
+IL-17
+ T cells and CD4
+ T cells from cultures as in (A) on day 5. (C) RT-PCR analysis of transcripts encoding ROR-gt, and IL-23R in cultures as
in part A and analyzed on day 5. (D) CD4
+CD25
+GFP
+ DEREG T cells were cultured for 5 days with wild-type BMDC plus soluble a-CD3 in the
presence of curdlan or IL-23 (10ng/mL). Cells were restimulated on day 5 with PMA, ionomycin and brefeldin A for 4h and the expression of Foxp3
and IL-17 on CD4
+ cell blasts was analyzed by ﬂow cytometry. (E) Numbers of Foxp3
+IL-17
+ T cells obtained in cultures as in part D. Data in part B
and E are mean+SEM of three independent experiments. Data are representative of two to four independent experiments. N.D., not done.
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cytometry. Alternatively, half of the content of each well were
restimulated on day 5 on plate-bound anti-CD3e (5mg/mL) for
48h before cytokines in the supernatant were analyzed by
sandwich ELISA.
Flow cytometry
Antibodies speciﬁc for CD4 (RM4-5), CD25 (PC61), CD62L
(MEL-14), CD44 (IM7) and CD3e (145-2C11) were from BD
Pharmingen. Antibodies against Folate receptor 4 (12A5), IL-17
(TC11-18H10.1) and Foxp3 (FJK-16s) were from eBiosciences.
For intracellular cytokine staining, cells were stained with anti-
CD4, ﬁxed and stained with anti-mouse/rat Foxp3 staining set
(eBiosciences) containing ﬂuorochrome-labeled antibodies. Data
were acquired on a FACSCalibur (BD Biosciences) and analyzed
using FlowJo software (Treestar).
RNA isolation and real-time RT-PCR
Total RNA was prepared with TRIzol reagent (Invitrogen). cDNA
was synthesized from total RNA with random hexamers and
Superscript II reverse transcriptase (Invitrogen). Quantitative
real-time PCR was carried out using SYBR green incorporation
(Il17f, ROR-(gt), Il23r). For SYBR green reactions, primer
sequences were as described previously [2, 5]. Measurements
were performed in duplicate wells using the ABI PRISM 7700
sequence detection system (Applied Biosystems). Normalization
was performed using 18S rRNA as a reference (primers and probe
from Applied Biosystems) and results are shown as relative
mRNA quantities.
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